The Company welcoms Dr. Boubakeur Belaroussi as Head of Product, Maartje Meijer as Head of Operations, Frank Cerrone as a lead MRI Technologist and Yeda Ford as a Head of Commercial Operations.
He is an internationally recognized immunologist with expertise in immune cell biology, cell engineering and immune-mediated disease.
Dr. Diana Roettger, Head of Scientific and Medical Affairs, is meeting with key biotech companies at the British Neuro-Oncology Society Conference (BNOS) at the University of Winchester from July 4-6, 2018.
IAG’s scientific team will present our 5 abstracts and 1 publication in inflammatory arthritis, osteoarthritis, degenerative and genetic muscle diseases, scleroderma, rare musculoskeletal diseases, including some that are based on machine learning and AI concepts.
Given the increasing need for collaboration in therapy development, Dr. Kubassova and Dr. Roettger will introduce IAG’s technology-enabled, risk-sharing and mitigation partnerships, and targeted development strategies.